A 15-year analysis of Australian clinical trial data underscores the significance of diversity in research topics and funding sources, impacting the future trajectory of Australian medical research. The study highlights challenges such as an imbalance in research types, limited collaboration among Australian researchers, and the importance of funding diversity. Dr. Anna Lene Seidler, lead researcher from the NHMRC Clinical Trials Centre at the University of Sydney, emphasises the critical role of public funding in supporting a well-rounded range of research that addresses vital health questions, including prevention. While Australia’s clinical trial activity is healthy, room for enhancement remains, particularly in data sharing, funding alignment, and diverse participation.
Global News and Digital Insights
for the Healthcare Industry
Menu
